<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_glomerular" title="Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate" shortTitle="glomerular" author="Caroline  C. Pelletier, Mikael Croyal, Lavinia Ene, Audrey Aguesse, Stephanie Billon-Crossouard, Michel Krempf, Sandrine Lemoine, Fitsum Guebre-Egziabher, Laurent Juillard, Christophe  O. Soulage" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6651/11/11/635/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
3.	LS	3.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
Identified	VBN	identify
mechanisms	NNS	mechanism
for	IN	for
target	NN	target
molecule	NN	molecule
elevation	NN	elevation
in	IN	in
CKD	NNP	CKD
patients	NNS	patient
are	VBP	be
either	CC	either
a	DT	a
decrease	NN	decrease
in	IN	in
renal	JJ	renal
excretion	NN	excretion
,	,	,
an	DT	a
increase	NN	increase
in	IN	in
endogenous	JJ	endogenous
production	NN	production
or	CC	or
both	DT	both
.	.	.
</s>
<s type="sub">
Thus	RB	thus
,	,	,
TMAO	NNP	TMAO
levels	NNS	level
could	MD	could
result	VB	result
from	IN	from
variations	NNS	variation
in	IN	in
production	NN	production
levels	NNS	level
(	-LRB-	(
including	VBG	include
dietary	JJ	dietary
precursor	NN	precursor
intake	NN	intake
,	,	,
TMA	NNP	TMA
endogenous	JJ	endogenous
production	NN	production
from	IN	from
gut	NN	gut
microbiota	NNS	microbiota
,	,	,
TMA	NNP	TMA
and	CC	and
TMAO	NNP	TMAO
intestinal	JJ	intestinal
absorption	NN	absorption
,	,	,
and	CC	and
FMO3	NNP	FMO3
enzymatic	JJ	enzymatic
activity	NN	activity
)	-RRB-	)
or	CC	or
from	IN	from
its	PRP$	its
renal	JJ	renal
excretion	NN	excretion
.	.	.
</s>
<s type="decl">
This	DT	this
study	NN	study
was	VBD	be
therefore	RB	therefore
designed	VBN	design
to	TO	to
assess	VB	assess
the	DT	the
exact	JJ	exact
changes	NNS	change
in	IN	in
TMAO	NNP	TMAO
values	NNS	value
according	VBG	accord
to	IN	to
CKD	NNP	CKD
stages	NNS	stage
as	IN	as
determined	VBN	determine
by	IN	by
gold	NN	gold
standard	NN	standard
measurements	NNS	measurement
of	IN	of
GFR	NNP	GFR
and	CC	and
its	PRP$	its
potential	JJ	potential
modifications	NNS	modification
during	IN	during
renal	JJ	renal
metabolism	NN	metabolism
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
,	,	,
we	PRP	we
confirmed	VBD	confirm
that	IN	that
TMAO	NNP	TMAO
is	VBZ	be
increased	VBN	increase
in	IN	in
CKD	NNP	CKD
based	VBN	base
on	IN	on
an	DT	a
inverse	JJ	inverse
,	,	,
although	IN	although
weak	JJ	weak
,	,	,
correlation	NN	correlation
(	-LRB-	(
<hi rend="italic">
r2	NN	r2
</hi>
=	SYM	=
0.388	CD	0.388
)	-RRB-	)
between	IN	between
plasma	NN	plasma
TMAO	NNP	TMAO
and	CC	and
mGFR	NN	mGFR
.	.	.
</s>
<s type="decl">
Surprisingly	RB	surprisingly
,	,	,
in	IN	in
all	DT	all
stages	NNS	stage
of	IN	of
CKD	NNP	CKD
,	,	,
we	PRP	we
did	VBD	do
not	RB	not
find	VB	find
any	DT	any
correlation	NN	correlation
between	IN	between
TMAO	NNP	TMAO
levels	NNS	level
and	CC	and
its	PRP$	its
precursors	NNS	precursor
,	,	,
except	IN	except
a	DT	a
weak	JJ	weak
correlation	NN	correlation
with	IN	with
carnitine	NN	carnitine
.	.	.
</s>
<s type="decl">
Measured	VBN	measure
clearances	NNS	clearance
of	IN	of
TMAO	NNP	TMAO
showed	VBD	show
a	DT	a
complete	JJ	complete
renal	JJ	renal
excretion	NN	excretion
of	IN	of
TMAO	NNP	TMAO
by	IN	by
glomerular	NN	glomerular
filtration	NN	filtration
with	IN	with
a	DT	a
steady	JJ	steady
FE	NN	FE
of	IN	of
105	CD	105
%	NN	%
during	IN	during
CKD	NNP	CKD
,	,	,
regardless	RB	regardless
of	IN	of
the	DT	the
stage	NN	stage
.	.	.
</s>
<s type="decl">
Unlike	IN	unlike
previous	JJ	previous
studies	NNS	study
,	,	,
we	PRP	we
reported	VBD	report
no	DT	no
evidence	NN	evidence
for	IN	for
effective	JJ	effective
contribution	NN	contribution
of	IN	of
tubular	JJ	tubular
excretion	NN	excretion
or	CC	or
reabsorption	NN	reabsorption
during	IN	during
renal	JJ	renal
clearance	NN	clearance
of	IN	of
TMAO	NNP	TMAO
.	.	.
</s>
<s type="decl">
In	IN	in
hemodialysis	NN	hemodialysis
patients	NNS	patient
,	,	,
we	PRP	we
confirmed	VBD	confirm
a	DT	a
greater	JJR	great
increase	NN	increase
in	IN	in
TMAO	NNP	TMAO
even	RB	even
though	IN	though
FR	NNP	FR
was	VBD	be
similar	JJ	similar
to	IN	to
that	DT	that
of	IN	of
urea	NN	urea
.	.	.
</s>
</p>
<p>
<s type="decl">
This	DT	this
study	NN	study
investigated	VBD	investigate
for	IN	for
the	DT	the
first	JJ	first
time	NN	time
TMAO	NNP	TMAO
levels	NNS	level
in	IN	in
all	DT	all
stages	NNS	stage
of	IN	of
CKD	NN	CKD
using	VBG	use
gold	NN	gold
standard	JJ	standard
measures	NNS	measure
of	IN	of
GFR	NNP	GFR
.	.	.
</s>
<s type="decl">
Results	NNS	result
of	IN	of
TMAO	NNP	TMAO
plasma	NN	plasma
concentrations	NNS	concentration
in	IN	in
CKD	NNP	CKD
were	VBD	be
in	IN	in
good	JJ	good
accordance	NN	accordance
with	IN	with
previous	JJ	previous
studies	NNS	study
.	.	.
</s>
<s type="decl">
Median	JJ	Median
TMAO	NNP	TMAO
plasma	NN	plasma
levels	NNS	level
found	VBD	find
herein	RB	herein
were	VBD	be
similar	JJ	similar
to	IN	to
those	DT	this
published	VBN	publish
by	IN	by
Stubbs	NNP	Stubb
et	NNP	et
al.	FW	al.
in	IN	in
<date when="2015">
2015	CD	2015
</date>
,	,	,
even	RB	even
though	IN	though
their	PRP$	their
data	NNS	datum
was	VBD	be
based	VBN	base
on	IN	on
estimated	VBN	estimate
GFR	NNP	GFR
.	.	.
</s>
<s type="decl">
Another	DT	another
study	NN	study
reported	VBD	report
a	DT	a
negative	JJ	negative
correlation	NN	correlation
between	IN	between
TMAO	NNP	TMAO
and	CC	and
mGFR	NN	mGFR
but	CC	but
both	DT	both
data	NNS	datum
sets	NNS	set
were	VBD	be
restricted	VBN	restrict
to	IN	to
CKD	NNP	CKD
stages	NNS	stage
3	CD	3
or	CC	or
more	RBR	more
severe	JJ	severe
.	.	.
</s>
<s type="decl">
To	IN	to
the	DT	the
best	NN	best
of	IN	of
our	PRP$	our
knowledge	NN	knowledge
,	,	,
no	DT	no
study	NN	study
has	VBZ	have
performed	VBN	perform
urinary	JJ	urinary
clearance	NN	clearance
measures	NNS	measure
of	IN	of
TMAO	NNP	TMAO
in	IN	in
CKD	NNP	CKD
.	.	.
</s>
<s type="decl">
Previously	RB	previously
,	,	,
Hai	NNP	Hai
et	FW	et
al.	FW	al.
published	VBD	publish
TMAO	NNP	TMAO
clearances	NNS	clearance
in	IN	in
control	NN	control
subjects	NNS	subject
,	,	,
reporting	VBG	report
a	DT	a
higher	JJR	high
clearance	NN	clearance
of	IN	of
TMAO	NNP	TMAO
compared	VBN	compare
to	IN	to
creatinine	NN	creatinine
,	,	,
suggesting	VBG	suggest
an	DT	a
active	JJ	active
secretion	NN	secretion
of	IN	of
TMAO	NNP	TMAO
.	.	.
</s>
<s type="decl">
Due	JJ	due
to	IN	to
its	PRP$	its
low	JJ	low
molecular	JJ	molecular
weight	NN	weight
(	-LRB-	(
75	CD	75
Da	NN	da
)	-RRB-	)
and	CC	and
soluble	JJ	soluble
non	RB	non
ionizable	JJ	ionizable
nature	NN	nature
,	,	,
with	IN	with
minimal	JJ	minimal
protein-bound	JJ	protein-bound
fraction	NN	fraction
,	,	,
we	PRP	we
consider	VBP	consider
TMAO	NNP	TMAO
to	TO	to
be	VB	be
entirely	RB	entirely
filtered	VBN	filter
through	IN	through
the	DT	the
glomerular	NN	glomerular
basement	NN	basement
membrane	NN	membrane
,	,	,
which	WDT	which
is	VBZ	be
the	DT	the
main	JJ	main
known	VBN	know
elimination	NN	elimination
route	NN	route
for	IN	for
TMAO	NNP	TMAO
.	.	.
</s>
<s type="decl">
Our	PRP$	our
results	NNS	result
showed	VBD	show
a	DT	a
likely	RB	likely
complete	JJ	complete
TMAO	NNP	TMAO
glomerular	NN	glomerular
filtration	NN	filtration
with	IN	with
a	DT	a
steady	JJ	steady
FE	NN	FE
of	IN	of
TMAO	NNP	TMAO
,	,	,
regardless	RB	regardless
of	IN	of
CKD	NNP	CKD
stages	NNS	stage
.	.	.
</s>
<s type="decl">
TMAO	NNP	TMAO
clearance	NN	clearance
was	VBD	be
similar	JJ	similar
to	IN	to
that	DT	that
of	IN	of
mGFR	NN	mGFR
,	,	,
higher	JJR	high
than	IN	than
that	DT	that
of	IN	of
urea	NN	urea
,	,	,
and	CC	and
lower	JJR	low
than	IN	than
that	DT	that
of	IN	of
creatinine	NN	creatinine
,	,	,
suggesting	VBG	suggest
that	IN	that
TMAO	NNP	TMAO
is	VBZ	be
neither	CC	neither
secreted	VBN	secrete
as	IN	as
creatinine	NN	creatinine
nor	CC	nor
reabsorbed	VBN	reabsorb
as	IN	as
urea	NN	urea
by	IN	by
renal	JJ	renal
tubules	NNS	tubule
.	.	.
</s>
<s type="decl">
We	PRP	we
however	RB	however
cannot	MD	cannot
exclude	VB	exclude
that	IN	that
the	DT	the
secretion	NN	secretion
rate	NN	rate
exactly	RB	exactly
matched	VBD	match
the	DT	the
reabsorption	NN	reabsorption
of	IN	of
TMAO	NNP	TMAO
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
high	JJ	high
fractional	JJ	fractional
reabsorption	NN	reabsorption
of	IN	of
sodium	NN	sodium
indicates	VBZ	indicate
that	IN	that
study	NN	study
participants	NNS	participant
had	VBD	have
no	DT	no
tubular	JJ	tubular
impairment	NN	impairment
,	,	,
which	WDT	which
reinforces	VBZ	reinforce
the	DT	the
validity	NN	validity
of	IN	of
these	DT	this
data	NNS	datum
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
IQR	NNP	IQR
of	IN	of
TMAO	NNP	TMAO
FE	NNP	FE
showed	VBD	show
that	IN	that
some	DT	some
patients	NNS	patient
exhibited	VBD	exhibit
higher	JJR	high
or	CC	or
lower	JJR	low
clearances	NNS	clearance
of	IN	of
TMAO	NNP	TMAO
compared	VBN	compare
to	IN	to
mGFR	NNP	mGFR
;	:	;
especially	RB	especially
in	IN	in
the	DT	the
control	NN	control
group	NN	group
where	WRB	where
the	DT	the
median	JJ	median
FE	NNP	FE
of	IN	of
TMAO	NNP	TMAO
was	VBD	be
103	CD	103
%	NN	%
[	-LRB-	[
IQR	NNP	IQR
55	CD	55
â€“	SYM	-
144	CD	144
]	-RRB-	]
.	.	.
</s>
<s type="decl">
This	DT	this
dispersion	NN	dispersion
could	MD	could
be	VB	be
explained	VBN	explain
by	IN	by
several	JJ	several
factors	NNS	factor
.	.	.
</s>
<s type="decl">
First	RB	first
,	,	,
urinary	JJ	urinary
clearance	NN	clearance
of	IN	of
TMAO	NNP	TMAO
was	VBD	be
not	RB	not
assessed	VBN	assess
at	IN	at
the	DT	the
exact	JJ	exact
same	JJ	same
time	NN	time
points	NNS	point
than	IN	than
mGFR	NN	mGFR
,	,	,
measured	VBN	measure
by	IN	by
inulin	NN	inulin
or	CC	or
iohexol	NN	iohexol
clearance	NN	clearance
.	.	.
</s>
<s type="sub">
Second	RB	second
,	,	,
the	DT	the
variability	NN	variability
of	IN	of
TMAO	NNP	TMAO
excretion	NN	excretion
could	MD	could
also	RB	also
be	VB	be
related	VBN	relate
to	IN	to
the	DT	the
amount	NN	amount
of	IN	of
ingested	VBN	ingest
TMA	NNP	TMA
precursors	NNS	precursor
.	.	.
</s>
<s type="decl">
We	PRP	we
unfortunately	RB	unfortunately
did	VBD	do
not	RB	not
administer	VB	administer
standardized	VBN	standardize
meals	NNS	meal
to	TO	to
avoid	VB	avoid
this	DT	this
bias	NN	bias
.	.	.
</s>
<s type="decl">
Yet	RB	yet
,	,	,
we	PRP	we
did	VBD	do
not	RB	not
find	VB	find
a	DT	a
significant	JJ	significant
correlation	NN	correlation
between	IN	between
plasma	NN	plasma
levels	NNS	level
of	IN	of
TMAO	NNP	TMAO
and	CC	and
total	JJ	total
protein	NN	protein
intake	NN	intake
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
several	JJ	several
studies	NNS	study
in	IN	in
animal	NN	animal
or	CC	or
cellular	JJ	cellular
models	NNS	model
have	VBP	have
shown	VBN	show
involvement	NN	involvement
of	IN	of
tubular	JJ	tubular
transporters	NNS	transporter
such	JJ	such
as	IN	as
organic	JJ	organic
cation	NN	cation
transporter	NN	transporter
2	CD	2
(	-LRB-	(
OCT2	NNP	OCT2
)	-RRB-	)
in	IN	in
TMAO	NNP	TMAO
cellular	JJ	cellular
uptake	NN	uptake
and	CC	and
efflux	NN	efflux
.	.	.
</s>
<s type="decl">
This	DT	this
,	,	,
however	RB	however
,	,	,
has	VBZ	have
not	RB	not
been	VBN	be
confirmed	VBN	confirm
in	IN	in
humans	NNS	human
unlike	IN	unlike
what	WP	what
has	VBZ	have
been	VBN	be
previously	RB	previously
described	VBN	describe
for	IN	for
creatinine	NN	creatinine
.	.	.
</s>
<s type="decl">
We	PRP	we
observed	VBD	observe
that	IN	that
elevation	NN	elevation
of	IN	of
TMAO	NNP	TMAO
is	VBZ	be
mostly	RB	mostly
due	JJ	due
to	IN	to
a	DT	a
decrease	NN	decrease
in	IN	in
mGFR	NN	mGFR
rather	RB	rather
than	IN	than
tubular	JJ	tubular
dysfunction	NN	dysfunction
.	.	.
</s>
<s type="decl">
These	DT	this
results	NNS	result
are	VBP	be
in	IN	in
line	NN	line
with	IN	with
another	DT	another
recent	JJ	recent
study	NN	study
reporting	VBG	report
that	IN	that
urinary	JJ	urinary
TMAO/creatinine	NN	tmao/creatinine
ratios	NNS	ratio
(	-LRB-	(
used	VBN	use
as	IN	as
a	DT	a
surrogate	NN	surrogate
of	IN	of
TMAO	NNP	TMAO
excretion	NN	excretion
rate	NN	rate
)	-RRB-	)
were	VBD	be
not	RB	not
significantly	RB	significantly
different	JJ	different
between	IN	between
control	NN	control
and	CC	and
CKD	NNP	CKD
subjects	NNS	subject
.	.	.
</s>
</p>
</text>